lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate
Labeler: camber pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate
Labeler
camber pharmaceuticals, inc.
Dosage Form
TABLET, CHEWABLE
Routes
Active Ingredients
lisdexamfetamine dimesylate 30 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
31722-323
Product ID
31722-323_37397df5-ba32-4489-a34b-81a61f5b860d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA217068
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2023-08-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
31722323
Hyphenated Format
31722-323
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate (source: ndc)
Application Number
ANDA217068 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 30 mg/1
Packaging
- 100 TABLET, CHEWABLE in 1 BOTTLE (31722-323-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "37397df5-ba32-4489-a34b-81a61f5b860d", "openfda": {"upc": ["0331722324014", "0331722323017", "0331722322010", "0331722325011", "0331722321013", "0331722326018"], "unii": ["SJT761GEGS"], "rxcui": ["1871456", "1871460", "1871462", "1871464", "1871466", "1871468"], "spl_set_id": ["f05bac63-08a5-49ce-8180-b33b76c0c0c4"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, CHEWABLE in 1 BOTTLE (31722-323-01)", "package_ndc": "31722-323-01", "marketing_start_date": "20230825"}], "brand_name": "LISDEXAMFETAMINE DIMESYLATE", "product_id": "31722-323_37397df5-ba32-4489-a34b-81a61f5b860d", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "31722-323", "dea_schedule": "CII", "generic_name": "lisdexamfetamine dimesylate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LISDEXAMFETAMINE DIMESYLATE", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "30 mg/1"}], "application_number": "ANDA217068", "marketing_category": "ANDA", "marketing_start_date": "20230825", "listing_expiration_date": "20261231"}